Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

2 ASX blue chip shares I’d buy for my portfolio

ASX blue chip shares are businesses that have can offer reliability and potential long-term growth, like Sonic Healthcare Ltd (ASX:SHL).

ASX blue chip shares are businesses that have the capability of both reliability and potential long-term growth.

I wouldn’t put businesses like BHP Group Ltd (ASX: BHP) or Telstra Corporation Ltd (ASX: TLS) in my portfolio because their medium-term and long-term profit growth is far from certain.

But I do believe that these two ASX blue chip shares are quality options in the ASX 50:

Macquarie Group Ltd (ASX: MQG)

Macquarie is by far my preferred financial pick of the large cap ASX shares.

Unlike the other big ASX banks, it’s not reliant on the mortgage market to generate profit. I think that’s an area of slow growth because it’s essentially a commodity product and total loan growth is pretty slow.

What I really like about Macquarie is its global operations. It has divisions generating earnings right across the world. That gives it good diversification and allows it to invest in any market in the world.

Macquarie has a substantial amount of earnings from defensive businesses, particularly from its assets management division. It’s one of the biggest infrastructure asset managers in the world.

The global investment bank recently reported its FY21 result came in at $3 billion, which was a 10% increase on FY20.

Sonic Healthcare Ltd (ASX: SHL)

Sonic is another ASX blue chip share that I’d really like to have in my portfolio.

The pathology business is partly a COVID-19 play for me. It has been doing millions of COVID-19 tests for its markets in the US and Europe.

Thankfully, the vaccinations are helping reduce the spread of COVID-19 in the northern hemisphere, but there’s still some way to go for a large proportion of people to be vaccinated and there’s a risk of other variants causing problems.

The COVID-19 testing is causing a dramatic jump in earnings for Sonic – FY21 half-year profit was up 166% to $678 million.

However, if COVID-19 testing calms down dramatically then its non-COVID operations can recover and grow further. There’s also the possibility of COVID-19 immunity testing growing into the future.

If Sonic can make a smart acquisition with all of this COVID-19 testing cashflow then it could lock-in much more growth for the non-COVID earnings per share (EPS).

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content